Figure 4 | Scientific Reports

Figure 4

From: Nicotinamide phosphoribosyltransferase is a molecular target of potent anticancer agents identified from phenotype-based drug screening

Figure 4

Antitumor activity of K542 in Xenograft model. (a) Tumor volume, (b) T/C ratio and (c) body weight change in HT-1080 xenograft models orally treated with vehicle or K542 (30 mg/kg, twice daily) for 12 days. Data indicate the mean ± s.e.m., n = 5. *p < 0.05, Wilcoxon’s rank sum test.

Back to article page